Identifying Skin Biopsy Sites

December 2, 2021 updated by: Murad Alam, Northwestern University

Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews

The primary objective of this study is to investigate the patient experience during skin biopsy.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University Dermatology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Physicians will be recruited by email obtained through directories.

Patients will be those who have had biopsies at the Northwestern University Department of Dermatology.

Description

Inclusion Criteria:

  • Age 18 and Over
  • The subjects are in good health.
  • The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
  • Patients who have had one or multiple skin biopsies OR board-certified dermatologists.

Exclusion Criteria:

  • Under 18 years of age.
  • Subjects who are unable to understand the protocol or give informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physicians
Physicians performing skin biopsies
Each group will be surveyed and interviewed.
Patients
Patients who have had skin biopsies
Each group will be surveyed and interviewed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Review of Physician and Patient Experience
Time Frame: Last four weeks of study

Subjects will answer a combination of:

  1. Open-ended questions and
  2. Questions asking for subject to rank possible responses
Last four weeks of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physician's Experience with Skin Biopsy Sites
Time Frame: First four weeks of study

Physicians will answer a combination of:

  1. Open-ended questions, and
  2. Questions asking for subject to rank possible responses
First four weeks of study
Patient's Experience with Skin Biopsy Sites
Time Frame: First four weeks of study

Patients will answer a combination of:

  1. Open-ended questions and
  2. Questions asking for subject to rank possible responses
First four weeks of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

June 27, 2012

First Submitted That Met QC Criteria

June 28, 2012

First Posted (Estimate)

July 3, 2012

Study Record Updates

Last Update Posted (Actual)

December 6, 2021

Last Update Submitted That Met QC Criteria

December 2, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STU66384

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Identification of Skin Cancer Biopsy Sites

Clinical Trials on Survey/Interview

Subscribe